
    
      We evaluate the effect of SJW on bosentan pharmacokinetics and its relationship to
      polymorphisms in the CYP2C9 gene known to reduce CYP2C9 activity. This study will be
      conducted at bosentan steady-state because concentrations decrease in the first 10 days of
      treatment due to auto-induction of the metabolism.
    
  